228 related articles for article (PubMed ID: 23054000)
1. Genetic variants in metabolizing genes NQO1, NQO2, MTHFR and risk of prostate cancer: a study from North India.
Mandal RK; Nissar K; Mittal RD
Mol Biol Rep; 2012 Dec; 39(12):11145-52. PubMed ID: 23054000
[TBL] [Abstract][Full Text] [Related]
2. Role of NQO1 609C>T and NQO2 -3423G>A gene polymorphisms in esophageal cancer risk in Kashmir valley and meta analysis.
Malik MA; Zargar SA; Mittal B
Mol Biol Rep; 2012 Sep; 39(9):9095-104. PubMed ID: 22736108
[TBL] [Abstract][Full Text] [Related]
3. Null association of NQO1 609C>T and NQO2 -3423G>A polymorphisms with susceptibility and prognosis of Esophageal cancer in north Indian population and meta-analysis.
Umar M; Upadhyay R; Kumar S; Ghoshal UC; Mittal B
Cancer Epidemiol; 2012 Dec; 36(6):e373-9. PubMed ID: 22770696
[TBL] [Abstract][Full Text] [Related]
4. NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.
Jamieson D; Wilson K; Pridgeon S; Margetts JP; Edmondson RJ; Leung HY; Knox R; Boddy AV
Clin Cancer Res; 2007 Mar; 13(5):1584-90. PubMed ID: 17332305
[TBL] [Abstract][Full Text] [Related]
5. Role of NQO1 609C>T and NQO2-3423G>A polymorphisms in susceptibility to gastric cancer in Kashmir valley.
Malik MA; Zargar SA; Mittal B
DNA Cell Biol; 2011 May; 30(5):297-303. PubMed ID: 21294640
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants of NQO1 gene increase bladder cancer risk in Indian population and meta-analysis.
Mandal RK; Dubey S; Panda AK; Mittal RD
Tumour Biol; 2014 Jul; 35(7):6415-23. PubMed ID: 24676794
[TBL] [Abstract][Full Text] [Related]
7. DNA repair gene X-ray repair cross-complementing group 1 and xeroderma pigmentosum group D polymorphisms and risk of prostate cancer: a study from North India.
Mandal RK; Gangwar R; Mandhani A; Mittal RD
DNA Cell Biol; 2010 Apr; 29(4):183-90. PubMed ID: 20070155
[TBL] [Abstract][Full Text] [Related]
8. No associations between Parkinson's disease and polymorphisms of the quinone oxidoreductase (NQO1, NQO2) genes.
Okada S; Farin FM; Stapleton P; Viernes H; Quigley SD; Powers KM; Smith-Weller T; Franklin GM; Longstreth WT; Swanson PD; Checkoway H
Neurosci Lett; 2005 Mar; 375(3):178-80. PubMed ID: 15694256
[TBL] [Abstract][Full Text] [Related]
9. NQO1 rs1800566 C>T polymorphism was associated with a decreased risk of esophageal cancer in a Chinese population.
Yin J; Wang L; Wang X; Zheng L; Shi Y; Shao A; Tang W; Ding G; Liu C; Liu R; Chen S; Gu H
Scand J Gastroenterol; 2014 Mar; 49(3):317-22. PubMed ID: 24354914
[TBL] [Abstract][Full Text] [Related]
10. Association analyses between polymorphisms of the phase II detoxification enzymes (GSTM1, NQO1, NQO2) and alcohol withdrawal symptoms.
Okubo T; Harada S; Higuchi S; Matsushita S
Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):68S-71S. PubMed ID: 12960511
[TBL] [Abstract][Full Text] [Related]
11. Association of caspases with an increased prostate cancer risk in north Indian population.
Mittal RD; Mittal T; Singh AK; Mandal RK
DNA Cell Biol; 2012 Jan; 31(1):67-73. PubMed ID: 21668377
[TBL] [Abstract][Full Text] [Related]
12. Association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population.
Zhang J; Schulz WA; Li Y; Wang R; Zotz R; Wen D; Siegel D; Ross D; Gabbert HE; Sarbia M
Carcinogenesis; 2003 May; 24(5):905-9. PubMed ID: 12771035
[TBL] [Abstract][Full Text] [Related]
13. NAD(P)H: quinone oxidoreductase 1 and NRH:quinone oxidoreductase 2 polymorphisms in papillary thyroid microcarcinoma: correlation with phenotype.
Lee J; Kim KS; Lee MH; Kim YS; Lee MH; Lee SE; Kim YK; Ryu MJ; Kim SJ; Choi MJ; Jo YS
Yonsei Med J; 2013 Sep; 54(5):1158-67. PubMed ID: 23918565
[TBL] [Abstract][Full Text] [Related]
14. NAD(P)H:quinone oxidoreductase 1 (NQO1) P187S polymorphism and prostate cancer risk in Caucasians.
Stoehr CG; Nolte E; Wach S; Wieland WF; Hofstaedter F; Hartmann A; Stoehr R
Int J Mol Sci; 2012; 13(9):10959-10969. PubMed ID: 23109831
[TBL] [Abstract][Full Text] [Related]
15. Polymorphism of xenobiotic-metabolizing genes and breast cancer susceptibility in North Indian women.
Singh V; Upadhyay G; Rastogi N; Singh K; Singh MP
Genet Test Mol Biomarkers; 2011 May; 15(5):343-9. PubMed ID: 21329464
[TBL] [Abstract][Full Text] [Related]
16. Interactions of the antioxidant enzymes NAD(P)H: Quinone oxidoreductase 1 (NQO1) and NRH: Quinone oxidoreductase 2 (NQO2) with pharmacological agents, endogenous biochemicals and environmental contaminants.
Rashid MH; Babu D; Siraki AG
Chem Biol Interact; 2021 Aug; 345():109574. PubMed ID: 34228969
[TBL] [Abstract][Full Text] [Related]
17. Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6.
Jaiswal AK; Burnett P; Adesnik M; McBride OW
Biochemistry; 1990 Feb; 29(7):1899-906. PubMed ID: 1691923
[TBL] [Abstract][Full Text] [Related]
18. Polymorphic variants of DNA repair gene XRCC3 and XRCC7 and risk of prostate cancer: a study from North Indian population.
Mandal RK; Kapoor R; Mittal RD
DNA Cell Biol; 2010 Nov; 29(11):669-74. PubMed ID: 20590474
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphism 609C>T in NAD(P)H:quinone oxidoreductase 1 enhances the risk of proximal colon cancer.
Freriksen JJ; Salomon J; Roelofs HM; Te Morsche RH; van der Stappen JW; Dura P; Witteman BJ; Lacko M; Peters WH
J Hum Genet; 2014 Jul; 59(7):381-6. PubMed ID: 24830960
[TBL] [Abstract][Full Text] [Related]
20. Clinical Significance of the NQO1 C609T Polymorphism in Non Small Cell Lung Adenocarcinoma Patients.
Masroor M; Jain A; Javid J; Mir R; Prashant Y; Imtiyaz A; Mariyam Z; Mohan A; Ray PC; Saxena A
Asian Pac J Cancer Prev; 2015; 16(17):7653-8. PubMed ID: 26625776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]